Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

bmiMD vs NuvaHealth

Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, NuvaHealth a 73. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

bmiMD

#11 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full bmiMD review →
VS

NuvaHealth

#160 · Grade C+ · Watch List

Est. first month

From $139/mo (first-month rate, compounded)

Save ~90% vs brand-name
Get this deal Full NuvaHealth review →

The verdict

Better value: bmiMD

bmiMD takes it on Value Score, 89 to 73 an est. $99/mo first month, with no teaser step-up baked in. NuvaHealth isn't out of it: Shoppers who want low first-month compounded GLP-1 pricing with 24/7 support.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealbmiMDNuvaHealth
Value Score89 (A)73 (C+)
Est. first month$99/moFrom $139/mo (first-month rate, compounded)
Save vs brand-name~93%~90%
Semaglutide$99/moFrom $139/mo (first-month rate, compounded)
Tirzepatide$139/moFrom $229/mo (first-month rate, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
84
bmiMD: 95. NuvaHealth: 84.
84
No Teaser-Rate Bait
64
bmiMD: 84. NuvaHealth: 64.
98
Nationwide Availability
45
bmiMD: 98. NuvaHealth: 45.
94
Both Molecules
98
bmiMD: 94. NuvaHealth: 98.
82
Easy Cancellation
58
bmiMD: 82. NuvaHealth: 58.
70
Reputation
73
bmiMD: 70. NuvaHealth: 73.

bmiMD

Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.

Why it's a deal

  • $99 flat semaglutide and a low $139 tirzepatide
  • Available in all 50 states
  • Both molecules priced up front

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Thin public track record; no oral or brand-name option

NuvaHealth

NuvaHealth (nuvahealth.org) is a LegitScript-certified compounded GLP-1 telehealth platform offering compounded semaglutide starting at $159 first-month and compounded tirzepatide starting at $259 first-month.

Why it's a deal

  • LegitScript Certified seal displayed on the marketing site (the standard third-party telehealth/pharmacy accreditation)
  • Free and fast delivery + 24/7 patient support disclosed on the home page
  • Newark, DE address suggests a US-incorporated entity (vs offshore)
  • $139 first-month price for compounded semaglutide injection is among the cheapest in the US compounded telehealth market
  • $229 first-month price for compounded tirzepatide injection sits in the lower-median range

The fine print

  • Standard ongoing monthly price NOT publicly disclosed (gated behind checkout) — patients should ask for the maintenance-dose price before committing
  • Specific legal entity name + state of incorporation NOT publicly disclosed on the home page — material YMYL transparency gap
  • Pharmacy partners NOT publicly named — material YMYL transparency gap
  • Per-state availability NOT enumerated; verify your state ships before purchase
  • Lab work + coaching support NOT publicly disclosed
Get the bmiMD deal Get the NuvaHealth deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to NuvaHealth.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.